MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > rapid-syphilis-testing as of june 1 2022

<< Previous

Bullboard Posts

Next >>

Comment by goldyhawkon Jun 24, 2022 8:01am

91 Views

Post# 34779589

RE:rapid-syphilis-testing as of june 1 2022

what concerns me is the need for a second clinical trial !!!!

how many trials do they want ??????????????????????

indecision abounds

HC is happy with having the appearance if doing something and depending on the FDA to show the way

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks